Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation

Pharmacotherapy

Volumn 16, Issue 6 I, 1996, Pages 1076-1084

  Shalansky, Karen F ^a,b   Fitzgerald, J Mark ^b   Sunderji, Rubina ^a,b   Traboulay, Susie J ^c   O'Malley, Byron ^a   McCarron, Bonnie I ^b   Naiman, Shelley ^a  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c SURREY MEMORIAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BODY WEIGHT; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MAINTENANCE THERAPY; MALE; NOMOGRAM; PARTIAL THROMBOPLASTIN TIME; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTICOAGULANTS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; THROMBOSIS;

EID: 0029825408     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Anderson FA. A population-based perspective of the hospital incidence and case-fatality rates of deep venous thrombosis and pulmonary embolism. Arch Int Med 1991;151:933-8.
2. Barrett DW. Anticoagulation drugs in the treatment of pulmonary embolism: a controlled clinical trial. Lancet 1960;1:1309-12.
3. Hull RD, Raskob GE, Hirsh J, et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. New Engl J Med 1986;315:1109-14.
4. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a standard care nomogram. Ann Int Med 1993;119:874-81.
5. Cruikshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard heparin nomogram for the management of heparin therapy. Arch Int Med 1991;151:333-7.
6. Elliot CG, Hiltunen SJ, Suchyta M, et al. Physician-guided treatment compared with a heparin protocol for deep-vein thrombosis. Arch Int Med 1994;154:999-1004.
7. Felding P, Bremmelgaard A, Winkel P. Adjusted-dose intravenous heparin treatment. Evaluation of an automated and a non-automated schedule. Thromb Res 1988;51:447-52.
8. Wheeler AP, Jaquiss RD, Newman JH. Physician practices in the treatment of pulmonary embolism and deep-vein thrombosis. Arch Int Med 1988;148:1321-5.
9. Ockelford P. Heparin 1986, indications and effective use. Drugs 1986;31:81-92.
10. Rivey MP, Peterson JP. Pharmacy-managed, weight-based heparin protocol. Am J Hosp Pharm 1993;50:279-84.
11. Gunnarsson PS, Sawyer WT, Montague D, Williams ML, Dupuis RE, Caiola SM. Appropriate use of heparin. Empiric vs nomogram-based dosing. Arch Intern Med 1995;155:526-32.
12. Levine MN, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108(suppl):276S-90S.
13. Hull RD, Raskob GE, Rosenbloom D, et al. Heparin for 5 days as compared to 10 days in the initial treatment of proximal vein thrombosis. N Engl J Med 1990,322:1260-4.
14. Hull RD, Raskob GE, Rosenbloom D, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med 1992;152:1589-95.
15. Hommes DW, Bura A, Mazzolai L, Buller HR, ten Cate JW. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep-vein thrombosis. A meta-analysis. Ann Intern Med 1992;116: 279-84.
16. Hirsh J. Heparin. N Engl J Med 1991;324:1565-74.
17. Basu D, Gallus A, Hirsh J, Cade JF. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972;287:324-7.
18. Hirsh J, vanAken WG, Gallus AS, et al. Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation 1976;53:691-5.
19. Simon TL, Hyers TM, Gaston JP, Harker LA. Heparin pharmacokinetics: increased requirements in pulmonary embolism. Br J Hematol 1978;39:111-20.
20. Tenero DM, Bell HE, Deitz PA, Bertino JS. Comparative dosage and toxicity of heparin sodium in the treatment of patients with pulmonary embolism versus deep-vein thrombosis. Clin Pharm 1989;8:40-3.
21. Cipolle RJ, Seifert RD, Neilan BA, Zaske DE, Haus E. Heparin kinetics: variables related to disposition and dosage. Clin Pharmacol Ther 1981;29:387-93.
22. Elliott CG, Michocki RJ, Brown R, Ottesen OE. Heparin requirements in pulmonary embolism and venous thrombosis: a prospective study. J Clin Pharmacol 1982;22:102-9.